Warby Parker (NYSE:WRBY) Misses Q2 CY2026 Revenue Estimates

Warby Parker (NYSE:WRBY) reported Q2 CY2026 revenue of $235.5 million, up 9.8% year on year, but below analysts’ estimates. Full-year revenue guidance was $967.5 million at the midpoint, about 1.3% under consensus. GAAP EPS of $0.04 matched expectations, and the stock fell 3.4% to $28.29 after the report.

Original reporting
Published Aug 6, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 1:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Warby Parker (NYSE:WRBY) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$WRBYBearishMed
01

Why it matters

Traders should weigh the guidance shortfall as the primary negative catalyst, while monitoring whether the margin/EBITDA strength and store growth can translate into improved revenue trajectory in later quarters.

02

Market read

A mixed earnings/guidance update: revenue under consensus and slightly light full-year revenue guidance, but GAAP EPS in line and EBITDA/gross margin beat.

03

What to watch

Store expansion (352 locations, 17.2% average annual growth over two years) and 9.8% YoY Q2 sales growth may indicate demand resilience that could offset the guidance shortfall over subsequent quarters.

Relevance 7/10Novelty 6/10Timing: post-Q2 earnings reaction, stock down 3.4% to $28.29 immediately after reporting

Background

Warby Parker reported Q2 CY2026 results with revenue growth but a miss versus Wall Street expectations, alongside full-year revenue guidance below consensus.

Company-level read

Ticker impact

$WRBYBearishMedium confidence
Context

Warby Parker missed Q2 CY2026 revenue expectations and guided full-year revenue to $967.5M midpoint, 1.3% below estimates.

Expected impact

Likely continued downside or underperformance versus peers until investors focus on margin/EBITDA strength and whether revenue guidance can be revised upward.

Evidence & confidence

Article cites revenue miss and slightly light full-year revenue guidance, while GAAP EPS matched and gross margin/EBITDA outperformed, creating a mixed setup but with guidance shortfall as the key risk.

Market effects

Signals ongoing pressure on consumer discretionary eyewear demand and/or pricing, but also shows retailers can beat margin/EBITDA even when revenue misses.

No specific regional impact described.

No explicit global supply-demand or international catalyst mentioned.

Counterpoint

The revenue miss is relatively small versus guidance and EPS was in line; margin and EBITDA outperformance could support a rebound if investors were overly focused on top-line.

Key entities

  • Warby Parker

    Eyewear retailer reporting Q2 CY2026 revenue miss and full-year revenue guidance of $967.5M midpoint.

Related articles

$WRBYMedAI 8/10

Warby Parker Q2 2026 earnings: profit on tariff refund

Warby Parker reported Q2 2026 profit of $4.6M versus a $1.75M loss a year earlier, helped by an $11.8M tariff refund benefit. Revenue rose 9.8% to $235.5M. Gross profit was $136.5M, and full-year net revenue guidance was reaffirmed at $959M to $976M, including $14.4M tariff benefit. The company expects an AI-powered eyewear launch within weeks, with no revenue contribution in guidance.

$WRBYMed

Warby Parker Inc. (WRBY): Results of Operations and Financial Condition

Warby Parker Inc. (WRBY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 warbyparkerincearningsrele.htm EX-99.1 Document Warby Parker Announces Second Quarter 2026 Results NEW YORK, August 6, 2026. Warby Parker Inc. (NYSE: WRBY) (“Warby Parker” or the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced

$YORWLow

YORK WATER CO (YORW): Results of Operations and Financial Condition

YORK WATER CO (YORW) filed an SEC Form 8-K — Results of Operations and Financial Condition. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report: August 6, 2026 (Date of earliest event reported) THE YORK WATER COMPANY (Exact name of registrant

$DANMedAI 8/10

Why is Dana stock surging today?

Dana Inc. shares rose about 9.1% in pre-open after the company reported mixed Q2 2026 results. Revenue was $2.01B versus $1.94B expected and $1.94B a year earlier. Adjusted EBITDA was $207M, a 10.3% margin. Management raised full-year targets and restarted its buyback program, despite adjusted EPS from continuing ops of $0.19 vs about $0.66 expected.

$COLLHighAI 9/10

Why is Collegium Pharmaceutical stock tumbling today?

Collegium Pharmaceutical shares fell about 13% in pre-open trading after it reported Q2 2026 results and cut full-year revenue guidance. Net revenues were $199.9M, up 6.3% but below analysts’ ~$201.2M-$201.4M. Adjusted EPS was $1.92 and adjusted EBITDA $113.8M. The pain portfolio faced generic competition, while JORNAY PM rose 41% to $46.1M and AZSTARYS added $12.9M.